NIH stem cell news - or is it?

Written byAlison McCook

| 1 min read

An interesting news release from the NIH landed in my inbox Tuesday (September 18). The headline said the agency "Announces Plan to Implement President's linkurl:Stem Cell;http://www.the-scientist.com/article/display/36654/ Executive Order." I know, I know -- the linkurl:executive order;http://www.the-scientist.com/news/display/53059/ came six years ago. But apparently, now the agency is taking new steps -- for instance, asking for grant applications to study non-embryonic sources of pluripotent cells, and creating two supplemental programs to augment already in-progress stem cell research. The plan also calls for "aggressively pursuing an assessment of the potential of alternative sources of pluripotent stem cell lines, " such as reprogramming somatic cells. "While these methods have been proposed, questions remain as to their feasibility. To address this issue, the NIH will undertake a comprehensive research portfolio review to determine what research NIH is currently supporting in this area and convene a state-of-the-science workshop to identify the key questions," the release notes. "Some of the alternative methods may raise questions under applicable law. In such cases, NIH must carefully consider whether it may fund such research. " That's an interesting comment. I wonder what it will mean. No one answered my phone call to the press contact listed on the release when I called this afternoon. The agency also plans to rename its Human Embryonic Stem Cell Registry the "Human Pluripotent Stem Cell Registry," and will consider adding new linkurl:human pluripotent;http://www.the-scientist.com/news/display/43099/ stem cell lines.

NIH stem cell news - or is it?

The Scientist ARCHIVES

Become a Member of

Meet the Author

Alison McCook

Related Research Resources

Wooden Neurons: An Artistic Vision of the Brain

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Driving Innovation with Cell Culture Essentials

Driving Innovation with Cell Culture Essentials

Human iPSC-derived Models for Neurodegenerative Disease Research

Exploring the Inflammatory Tumor Microenvironment

Products

Product News

Beckman Coulter Life Sciences Introduces the Biomek i3 Benchtop Liquid Handler, a Small but Mighty Addition to its Portfolio of Automated Workstations

BRANDTECH® Scientific Announces Strategic Partnership with Copia Scientific to Strengthen Sales and Service of the BRAND® Liquid Handling Station (LHS)

Enter Our 2026 Top Innovations Contest

Biotium Expands Tyramide Signal Amplification Portfolio with Brighter and More Stable Dyes for Enhanced Spatial Imaging